Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
NCT ID: NCT04173026
Last Updated: 2023-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2020-06-04
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reproducibility Study of Transcranial Doppler
NCT03050567
Quality of Life After Stroke Using a Telemedicine-based Stroke Network
NCT02447094
The Care of Stroke in Ziekenhuis Oost-Limburg
NCT03355690
Tele-Stroke: Prehospital Identification of Patients With Suspected Stroke Using Onsite Mobile Telemedicine - Feasibility
NCT03370094
Telestroke 2: Prehospital Triage of Patients With Suspected Stroke Using Onsite Mobile Telemedicine
NCT04578002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Provider intervention
A web-based application called ProviderMinder has been developed and will be used to alert providers when a patient who has been lost-to-follow-up or has missed their Sickle Stroke Screen (TCD). This will allow providers to follow up with such patients and improve screening rates.
Provider-level intervention
Provider minder is a provider-based scheduling and reminder system for stroke screening in SCD
Provider and Patient level intervention
A web-based application called ProviderMinder has been developed and will be used to alert providers when a patient who has been lost-to-follow-up or has missed their Sickle Stroke Screen (TCD). This will allow providers to follow up with such patients and improve screening rates. Additionally, sites will have a patient intervention of a single Sickle Stroke Screen coordinator who will interact directly with patients to schedule, reschedule, remind, and follow-up on stroke screening. This person will also act as a point of contact for any educational needs the patient may have. The second patient intervention will include the caregivers own mobile device. When Sickle Stroke Screens are scheduled the coordinator will ensure these appointments are directly put into the caregiver's mobile device calendar acting as an additional reminder for stroke screening.
Provider-level intervention
Provider minder is a provider-based scheduling and reminder system for stroke screening in SCD
Patient-level intervention
50% of centers are randomized to a single stroke screen coordinator as the point of contact for sickle stroke screen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Provider-level intervention
Provider minder is a provider-based scheduling and reminder system for stroke screening in SCD
Patient-level intervention
50% of centers are randomized to a single stroke screen coordinator as the point of contact for sickle stroke screen
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must have been seen by the designated institution (documented in medical record) a minimum of two times in the either inpatient or outpatient setting at the institution between the years of 01/01/2018-12/31/2019.
* Patients identified will include those currently aged 2-7. Thus children born from 2012 and onward.
* Patients already receiving primary or secondary stroke prevention therapy with CRCT will be included in registration in Web Data Coordination Unit (WEBDCU) but not included in PROVIDER MINDER as they do not require ongoing TCD/SICKLE STROKE SCREEN based on protocol.
Exclusion Criteria
* Patients who were born before 2012 and therefore do not meet age criteria.
2 Years
7 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julie Kanter
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie Kanter, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Research Institute
Little Rock, Arkansas, United States
UCSF Benioff Children's Hospital Oakland
Oakland, California, United States
Nemours Center for Cancer & Blood Disorders
Wilmington, Delaware, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Howard University Hospital
Washington D.C., District of Columbia, United States
Broward Health Medical Center
Fort Lauderdale, Florida, United States
University of Florida Health Shands Children's Hospital
Gainesville, Florida, United States
University of Miami
Miami, Florida, United States
Children's Heathcare of Atlanta
Atlanta, Georgia, United States
University of Illinois at Chicago
Chicago, Illinois, United States
SSM Health Cardinal Glennon Children's Hospital
St Louis, Missouri, United States
St. Louis Children's Hospital
St Louis, Missouri, United States
Columbia University Medical Center
New York, New York, United States
Vidant Medical Center
Greenville, North Carolina, United States
Vanderbilt Children's Hospital
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH 5R01HL133896-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.